AACR to Receive $2 Million to Support Innovative Research from UBS Oncology Impact Fund Managed by MPM Capital
PHILADELPHIA – The American Association for Cancer Research (AACR) will receive $2 million from the UBS Oncology Impact Fund...
PHILADELPHIA – The American Association for Cancer Research (AACR) will receive $2 million from the UBS Oncology Impact Fund...
PHILADELPHIA — The Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research will be presented to John E....
PHILADELPHIA – The loss of one copy of the miR15a/miR16-1 gene cluster promoted initiation and progression of multiple myeloma...
PHILADELPHIA – Compared with individuals without a history of dengue virus infection, those previously infected with the virus had...
PHILADELPHIA — T cells targeting p53 hotspot mutations can be harvested from peripheral blood of patients with metastatic solid epithelial cancers, according to...
Team Supported by Generous Grants from the Cless Family Foundation and Sara & Jeff Schottenstein Family Charitable Fund SANTA...
PHILADELPHIA — The targeted therapy combination of the mTOR inhibitor everolimus (Afinitor) and the somatostatin agonist octreotide (Sandostatin) yielded...
PHILADELPHIA — Adolescent and young adults who survived at least two years after a cancer diagnosis had nearly double...
Study reports the landscape of mutations present in pediatric acute lymphoblastic leukemia (ALL) and how this landscape changes during...
PHILADELPHIA —American cancer survivors, particularly those 64 years or younger, faced substantial medical financial hardship and sacrifices in spending,...